 Tandem Diabetes Care Inc NASDAQ: TNDM reported Q3 sales of 179.6 million, 45 YY, beating the consensus of 171.41 million. The Company posted EPS of 0.09, a turnaround from a loss of 0.15 and beating the Wall Street estimate of 0.06. 